Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implantation | 19 | 2025 | 52 | 6.580 |
Why?
|
| Cochlear Implants | 17 | 2025 | 58 | 5.850 |
Why?
|
| Speech Perception | 16 | 2025 | 58 | 5.380 |
Why?
|
| Tinnitus | 2 | 2023 | 23 | 0.990 |
Why?
|
| Neuroma, Acoustic | 5 | 2025 | 31 | 0.890 |
Why?
|
| Temporal Bone | 3 | 2021 | 38 | 0.880 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2022 | 8 | 0.810 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2022 | 157 | 0.770 |
Why?
|
| Reoperation | 2 | 2025 | 864 | 0.750 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2020 | 17 | 0.680 |
Why?
|
| Encephalocele | 1 | 2020 | 50 | 0.650 |
Why?
|
| Retrospective Studies | 26 | 2025 | 17380 | 0.640 |
Why?
|
| Paranasal Sinuses | 1 | 2019 | 21 | 0.630 |
Why?
|
| High Fidelity Simulation Training | 1 | 2019 | 6 | 0.630 |
Why?
|
| Scalp | 1 | 2019 | 59 | 0.630 |
Why?
|
| Free Tissue Flaps | 1 | 2019 | 59 | 0.610 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 83 | 0.610 |
Why?
|
| Adenoidectomy | 1 | 2019 | 79 | 0.600 |
Why?
|
| Endoscopy | 2 | 2024 | 289 | 0.580 |
Why?
|
| Tonsillectomy | 1 | 2019 | 105 | 0.560 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 297 | 0.500 |
Why?
|
| Patient Readmission | 1 | 2019 | 404 | 0.490 |
Why?
|
| Treatment Outcome | 18 | 2025 | 12957 | 0.490 |
Why?
|
| Prosthesis Failure | 2 | 2025 | 168 | 0.430 |
Why?
|
| Radiosurgery | 3 | 2025 | 128 | 0.410 |
Why?
|
| Hearing | 5 | 2025 | 62 | 0.380 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 1137 | 0.370 |
Why?
|
| Adult | 19 | 2025 | 31851 | 0.360 |
Why?
|
| Deafness | 2 | 2023 | 85 | 0.360 |
Why?
|
| Osteoradionecrosis | 2 | 2021 | 17 | 0.360 |
Why?
|
| Humans | 34 | 2025 | 133290 | 0.310 |
Why?
|
| Microsurgery | 2 | 2025 | 72 | 0.280 |
Why?
|
| Ear, Inner | 2 | 2025 | 50 | 0.260 |
Why?
|
| Otoscopy | 1 | 2024 | 8 | 0.230 |
Why?
|
| Mastoidectomy | 1 | 2024 | 6 | 0.230 |
Why?
|
| Quality of Life | 3 | 2024 | 2120 | 0.230 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2024 | 13 | 0.230 |
Why?
|
| Equipment Failure | 1 | 2025 | 131 | 0.230 |
Why?
|
| Ear Diseases | 1 | 2024 | 20 | 0.230 |
Why?
|
| Glomus Tympanicum | 1 | 2024 | 2 | 0.220 |
Why?
|
| Male | 16 | 2025 | 65619 | 0.220 |
Why?
|
| Hearing Loss | 2 | 2025 | 212 | 0.220 |
Why?
|
| Presbycusis | 1 | 2023 | 4 | 0.210 |
Why?
|
| Cadaver | 2 | 2023 | 136 | 0.200 |
Why?
|
| Patient Preference | 1 | 2024 | 135 | 0.200 |
Why?
|
| Diathermy | 1 | 2022 | 4 | 0.200 |
Why?
|
| Aged | 12 | 2025 | 21619 | 0.200 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2025 | 280 | 0.200 |
Why?
|
| Language | 1 | 2023 | 218 | 0.190 |
Why?
|
| Electrodes, Implanted | 1 | 2022 | 175 | 0.190 |
Why?
|
| Female | 15 | 2025 | 71345 | 0.180 |
Why?
|
| Radiotherapy, Conformal | 1 | 2021 | 63 | 0.180 |
Why?
|
| Otosclerosis | 1 | 2021 | 4 | 0.180 |
Why?
|
| Pentoxifylline | 1 | 2020 | 20 | 0.180 |
Why?
|
| Differential Threshold | 1 | 2020 | 11 | 0.170 |
Why?
|
| Labyrinthitis | 1 | 2020 | 10 | 0.170 |
Why?
|
| Auditory Cortex | 1 | 2020 | 30 | 0.170 |
Why?
|
| Anticoagulants | 1 | 2025 | 595 | 0.170 |
Why?
|
| Dehydration | 1 | 2019 | 41 | 0.160 |
Why?
|
| Brain Stem | 1 | 2020 | 120 | 0.160 |
Why?
|
| Gelatin | 1 | 2019 | 17 | 0.160 |
Why?
|
| Microvessels | 1 | 2019 | 63 | 0.160 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 136 | 0.160 |
Why?
|
| Middle Aged | 10 | 2025 | 29237 | 0.160 |
Why?
|
| Virtual Reality | 1 | 2019 | 32 | 0.150 |
Why?
|
| Postoperative Period | 1 | 2019 | 347 | 0.150 |
Why?
|
| Models, Anatomic | 1 | 2019 | 103 | 0.150 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 265 | 0.150 |
Why?
|
| Random Allocation | 1 | 2019 | 452 | 0.150 |
Why?
|
| Child, Preschool | 3 | 2025 | 14748 | 0.140 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 7184 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 1311 | 0.140 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2019 | 168 | 0.130 |
Why?
|
| Infant | 2 | 2024 | 13107 | 0.130 |
Why?
|
| Age Factors | 2 | 2021 | 2971 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2024 | 1057 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 692 | 0.120 |
Why?
|
| Child | 4 | 2025 | 25678 | 0.120 |
Why?
|
| Audiometry, Pure-Tone | 2 | 2025 | 25 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2019 | 738 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 905 | 0.110 |
Why?
|
| Time Factors | 2 | 2024 | 6562 | 0.100 |
Why?
|
| Machine Learning | 2 | 2023 | 325 | 0.080 |
Why?
|
| Adolescent | 3 | 2025 | 20480 | 0.080 |
Why?
|
| Medicare | 2 | 2022 | 464 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2019 | 1249 | 0.070 |
Why?
|
| Obesity | 1 | 2020 | 2405 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2019 | 8560 | 0.060 |
Why?
|
| Ear Neoplasms | 1 | 2025 | 14 | 0.060 |
Why?
|
| Tympanoplasty | 1 | 2024 | 11 | 0.060 |
Why?
|
| Mastoid | 1 | 2024 | 25 | 0.060 |
Why?
|
| Neurilemmoma | 1 | 2025 | 47 | 0.060 |
Why?
|
| Hearing Aids | 1 | 2024 | 33 | 0.060 |
Why?
|
| Petrous Bone | 1 | 2023 | 5 | 0.050 |
Why?
|
| Endoscopes | 1 | 2023 | 20 | 0.050 |
Why?
|
| Speech | 1 | 2024 | 81 | 0.050 |
Why?
|
| Cranial Sinuses | 1 | 2023 | 12 | 0.050 |
Why?
|
| Video Recording | 1 | 2024 | 202 | 0.050 |
Why?
|
| Electrosurgery | 1 | 2022 | 16 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2025 | 220 | 0.050 |
Why?
|
| Tocopherols | 1 | 2020 | 8 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 5481 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 286 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2022 | 624 | 0.040 |
Why?
|
| Patient Selection | 1 | 2023 | 731 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2019 | 92 | 0.040 |
Why?
|
| Urban Population | 1 | 2021 | 240 | 0.040 |
Why?
|
| Young Adult | 2 | 2025 | 9872 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 750 | 0.030 |
Why?
|
| United States | 2 | 2022 | 11633 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1314 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2023 | 3629 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1726 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 2214 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 3983 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 6629 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 3381 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 3665 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 5065 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 3836 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 11006 | 0.020 |
Why?
|